EQS-News: CHEPLAPHARM opens presence in Tokyo
CHEPLAPHARM Arzneimittel GmbH, based in Greifswald/Germany, has opened a presence in the Japanese capital Tokyo and obtained the pharmaceutical licence for Japan.
- CHEPLAPHARM Arzneimittel GmbH, based in Greifswald/Germany, has opened a presence in the Japanese capital Tokyo and obtained the pharmaceutical licence for Japan.
- The managing director of the founded CHEPLAPHARM KK is Kentaro Ichimori, who most recently held a leading position for Sandoz in Japan.
- Establishing a presence in Japan and launching CHEPLAPHARM as a local brand is important to further build trust with local business partners, doctors and patients.
- The opening of an office in Tokyo and the presence on the Japanese market serves to establish CHEPLAPHARM as a brand in Japan and make it better known, thus leveraging further growth potential.